|
TeleHealth Seminars
-2010
-2009
-2008
-2007
-2006
MLA Education Day
-2010
-2009
-2008
-2006
The Real CSI
-2010
National Med Lab Week Videos
Toxicology and the Natural World
Perimenopause
|
 |
Archived Events
Telehealth Seminars 2010 |
June 15: Biomarkers of Sepsis: Sounding the Early Alarm
with Dr. Nancy Haley
Sepsis is a complex clinical syndrome that is a leading cause of death worldwide. Onset can be rapid, with mortality occurring in as little as 24-48 hours. Pathogenesis is often associated with the “cytokine storm”, an uncontrolled response of the immune system, which can lead to hemodynamic instability and organ failure. Clinical symptoms alone are often insufficient for an early and accurate diagnosis, reducing an already limited window for effective treatment. Emerging biomarkers of sepsis may allow a more rapid and accurate diagnosis, resulting in earlier intervention and improved patient outcomes.
Seminar CEU Objectives
At the conclusion of the seminar, attendees should be able to:
- Describe the current definition of sepsis
- Understand the differences between the systemic inflammatory response (SIRS) and sepsis, severe sepsis, and septic shock
- Identify the clinical value for early identification of sepsis
Dr. Nancy Haley received her doctoral degree from St. John’s University in New York in Biochemistry. She trained at the Rockefeller University in cardiovascular…for full Bio, click here
Presentation in PDF format
_______________________
May 13th: Cryptococcal Disease in BC
with Dr. Bartlett
A veterinarian was the first to notice an increasing number of cases of cryptococcal disease in British Columbia. In 2000, a medical microbiologist reported to the BC CDC the unusual finding of cryptococcal disease in non-immunocompromised patients. Thus begins the story of the discovery of Cryptococcus gattii, formerly known as C. neoformans var. gattii – and formerly thought to only inhabit tropical climes. Until 2004 it was thought the organism was confined to Vancouver Island, until cases were seen on the Mainland BC, Washington state, and more recently, Oregon. C. gattii is a fascinating example of a pathogenic agent of an emerging disease turning up in a new ecologic niche – and the challenges that presents for public health. We’ll get the inside story on C. gattii inside and outside the laboratory in this tele-health conference.
Dr. Bartlett holds a Masters degree in Occupational
Hygiene and a doctorate in Interdisciplinary Studies
from the University of British Columbia....for more info click here
Presentation in PDF format
_______________________
April 21: Heart Disease in Women
with Dr. Margaret Blackwell
“Heart disease is still the number one killer of women in Canada. Dr. Blackwell, a Cardiologist at Royal Columbian Hospital, will explore evidence based studies of Heart Disease in Women. Attendees will learn all about the Reynolds Risk Score in determining the dangers and potential risk of heart disease in women”
Margaret Blackwell:
LPN, RN, Assistant Head Nurse ICU
MD UBC 1988
FRCPC Internal Medicine UBC 1994
FRCPC Cardiology 1996
FACC
Assistant Clinical Professor Medicine UBC
Cardiologist Royal Columbian Hospital
Presentation in PDF format
_______________________
March 31 , 2010: Breast Cancer in 2010
with Dr. Karen Gelmon
This presentation will include a review of the following…
- Risk factors for breast cancer and prevention measures and trials
- Screening in 2010 - who and how
- How we conceptualize breast cancer and how that affects treatment
- Improved outcomes in breast cancer and multidisciplinary care model
Dr. Gelmon is a Professor of Medicine at the UBC and a Medical Oncologist at the BC Cancer Agency, combining clinical and translational research. She is Co Chair of the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) Breast Site Committee and a member of The Breast Cancer Intergroup Committee (TBCI, formerly the North American Breast Intergroup) and of the Breast International Group (BIG). She is past Chair of the Investigational ...click here for more
Presentation in PDF format
_______________________
January 21: Patient Safety Culture – Implementing and
Sustaining it in the Medical Laboratory
with Susan Thomas, MA, ART
The term ‘safety culture’ was first used in a 1988 report prepared by the International Nuclear Safety Advisory Group on the Chernobyl nuclear disaster. The term ‘patient’ safety culture came sharply to the attention of the public and medical professionals in a report from the Institute of Medicine (2000) which recommended that a change in culture was essential in order to avoid tens of thousands of patient deaths annually caused by preventable medical error. There are many patient safety-focused initiatives underway at the federal, provincial and health authority level that share the same intent – to shift culture across our healthcare organizations...more info click
Presentation in PDF format
<Back to top>
|
| TeleHealth Seminars 2009 |
December 17: QC and EQA to Achieve Interlaboratory Harmonization
with Dr. John Penman, VIHA
I think the topic is very practically oriented toward the bench technologist as much quality resource staff. My recent experience here in the Vancouver Island Health Authority shows that bench technologists are involved in much of the day to day quality processes, not only running regular QC, but submitting and reviewing regular EQA submissions and results. More importantly, the processes of instrument maintenance and calibration feed directly into quality and quality monitoring, and the BC directive to standardize processes and harmonize services within and among health authorities make this a subject needing broad awareness.
The presentation would take a broad view of quality and harmonization, and the components that are important to achieving these. Practical ideas on processes and systems to improve these is the meat of the presentation and are based on my practical experience chairing a quality and harmonization initiative for global laboratories providing lab services to global clinical research studies.
Presentation in PDF format
November 19: Human Papillomavirus (HPV): Epidemiology, Diagnosis and Prevention
with Dr. Mel Krajden MD, FRCP(C)
This lecture will:
1) Review HPV epidemiology and highlight its role in causing cervical cancer
2) Discuss current and future diagnostic tools to detect and type HPV infections
3) Review the status of HPV vaccine prevention efforts
Presentation in PDF format
_______________________
October 29: Islet Pathology and Disease Pathogenesis in Type 1 and Type 2 Diabetes
with Dr. Bruce Verchere
Diabetes mellitus impacts ~2.5 million Canadians, shortens life span and causes devastating complications, and costs the Canadian health care system approximately 15 billion dollars annually. Type 1 diabetes - accounting for about 10% of all diabetes - is an autoimmune disease in which the insulin-producing beta cells of the pancreas are specifically targeted and destroyed by one’s own immune system, leaving patients dependent on insulin by injection for life. Type 2 diabetes, the more common form of the disease, is associated with obesity and aging and ....
Presentation in PDF format
_______________________
June 18 :
The Emerging Utility of Molecular Diagnostics and Personalized Medicine in the Laboratory
Dr. Karen Mooder, BSc, PhD, RT (CSMLS)
The Human Genome Project has provided us with data that will forever change our understanding about the genetic etiology of human disease. While the Mendelian paradigm of genetic expression has held fast for decades, our advancing knowledge about the genetic and epigenetic mechanisms controlling DNA, RNA and protein expression will significantly alter our approach to laboratory diagnosis of complex disease. Molecular diagnostic tests are being adopted into clinical laboratory test menus at an ever increasing rate. To date, the greatest utility for molecular diagnostics has been found in the areas of molecular oncology, pathogen detection and to a lesser extent, hemostasis. However, there is great opportunity for molecular diagnostics to be applied broadly across the clinical laboratory. This session will explore a number of facets related to the development and uptake of molecular diagnostics including the relationship of human population genetics to pathophysiology, the emerging field of pharmacogenomics and technological advances in genetic detection platforms. This session will also examine the numerous challenges associated with research and development of molecular diagnostics.
Presentation in PDF format
_______________________
May 27: Bacterial Identification in the 21st Century;
The Application of Nucleic Acid Techniques for the Identification of Bacteria in Clinical Samples
with Alan McNabb
, B.Sc., ART
CANCELLED
....Alan McNabb’s laboratory has been activated as the swine flu typing laboratory for the province during the swine flu epidemic. All staff including Alan are inundated with the workload. Since we do not know the extent or duration of this outbreak he is afraid that this will not allow him to prepare and present the Telehealth session on May 27th. So unfortunately he will have to postpone the session on Bacterial Identification until a later date. Probably in the Fall.
_______________________
April 16: Delving into the Quality Toolbox
Dr. Michael Noble
In Part 2, we will discuss some of the tools that the Quality Manager and Quality Team use to implement a quality structure: quality indicators, risk management tools, and the elements of Six Sigma, LEAN.
In Part 1(February Telehealth) Dr. Noble re-introduced the audience to Laboratory Quality Management, and its origins back almost 100 years ago. We talked about the concepts of Henry Ford, Water Shewhart and Edwards Deming, and Phillip Crosby and their influences on the standards used today.
Presentation in PDF format
_______________________
March 26 : HIV Infection as a Chronic InflammatoryDisease – Implications for the Optimal Use of HAART
Dr. Julio Montaner
There is a growing understanding of the consequences of chronic inflammation due to uncontrolled HIV replication over time. Chronic inflammation related to HIV replication has been implicated as a major driver of atherosclerosis and cardiovascular disease, increased risk of myocardial infarction, stroke, and end organ damage (i.e.: liver, kidneys, etc) among HIV infected individuals. Patients with uncontrolled HIV replication have increased ongoing inflammation such as fibrinogen, C-reactive protein (CRP), d-dimer and interleukin-6. Recently, reported results from the SMART trial showed an impressive increase in interleukin-6 and d-dimer levels with increased plasma viral load as a result of treatment discontinuation. Furthermore, higher interleukin-6 and d-dimer levels were strongly associated with mortality. The new understanding of HIV infection as a chronic inflammatory disease coupled with the development of simpler, less toxic regimens, have spurred a renewed enthusiasm in support of earlier initiation of therapy in asymptomatic individuals.
Presentation in PDF format
_______________________
February 19: Getting Accreditation Ready!
Dr. Michael Noble
Laboratory Quality Management is not new. Its origins can be traced back almost 100 years ago through such luminaries as Henry Ford, Water Shewhart and Edwards Deming, and go all the way forward to today. During this presentation we will address the history and evolution in detail. Furthermore quality requires the foundational base, a coderie of personnel including a Quality Manager and a Quality Team that require new knowledge and provide new functions that can improve confidence in laboratory care. There is a new language that has become part of the laboratory landscape: Six Sigma, LEAN, and ISO15189. What do they mean and where do they fit, and how will they change what we do?
Presentation in PDF format
_______________________
January 15: Emergency Planning in Hospitals
Cecil Unrau
Do you know how to react when receiving contaminated patients and what the decontamination process would look like? Do you know what role labs may play in a bioterrorism event?
Cecil Unrau will show you…As a member of the Provincial Hazardous Substance Planning Committee; he is currently developing provincial response standards (Protocols, Training, Equipment) for mass casualty events involving patient decontamination. It is expected that all health facilities have a measure of readiness as we prepare for the 2010 Olympic Winter Games and beyond.
No presentation is available
Back to Top
|
| TeleHealth Seminars 2008 |
November 26: PSA - To Screen or Not to Screen
Dr. Richard Cleve
It’s a question many physicians and patients have had to grapple with over the years. Proponents argue PSA catches cancer sooner. Naysayers argue it leads to a lot of wrong diagnoses and needless anxiety. We’ll explore some of the recent medical literature on the subject and also consider some laboratory concerns around the test.
Presentation in PDF format
October 16: Experience and Expectations: eGFR Reporting in Canada
Dr. David Seccombe
This presentation examined the impact of the post-analytical standardization program for creatinine and the routine reporting of eGFR by the clinical laboratories in BC.
Evidence-based clinical practice guidelines are now recommending that an estimation of glomerular filtration rate (eGFR) be used for the routine assessment of renal function. The National Kidney Foundation (NKF-US) Kidney Disease Outcomes Quality Initiative Advisory Board in the United States and the Canadian Society of Nephrology have supported this recommendation and are asking clinical laboratories to routinely report an estimate of GFR for adult patients. The Modification of Diet in Renal Disease (MDRD) equations are recommended for this purpose as they are based upon the patient’s age, gender and serum creatinine test result and do not require the patient’s weight. In March of 2004, British Columbia introduced a program to standardize the measurement of creatinine in 107 clinical laboratories in an effort to minimize the contribution of laboratory testing error to the reporting of eGFR and to reduce on a province wide basis the rates of miss-classification. The program was introduced as an interim strategy pending standardization of creatinine testing by instrument manufacturers – a process that was estimated to be completed by 2009.
Presentation in PDF format
May 22: Cholesterol
Dr. Richard Cleve
This TeleHealth Video Broadcast looked at current knowledge on cholesterol from a noted expert in the field, with experience in educating medical laboratory professionals in this essential cardiovascular area.
The presenter, Dr. Richard Cleve, obtained his BSc in biochemistry at Brock University, St. Catharines ON, a MSc in physics from University of Guelph, Guelph ON, and his MD from the University of Western Ontario, London ON.
He then went on to do a residency in medical biochemistry at McMaster University, Hamilton ON. After residency he took a position with C.J. Coady Associates and started working at B.C. Biomedical labs in October.
Starting in January he also serves as the biochemist at Surrey Memorial Hospital and a consultant biochemist to Peace Arch and Delta Hospitals.
Representation in PDF format
April 17: Microbiology for Public Health: The Role of Medical Laboratories
Dr. J.L Isaac-Renton
This TeleHealth Video Broadcast covered the role of clinical and diagnostic microbiology labs in acute care, community, and public health reference settings, and how the different microbiology disciplines relate to specific communicable diseases of public health relevance. Included were the Core Functions of Public Health Labs, how they relate to the work of medical laboratory professionals, and how they benefit residents in BC and Canada.
The presenter, Dr. J.L. Isaac-Renton, is Director of Laboratory Services at the BC Centre for Disease Control and Professor of Medical Microbiology at UBC.
Judy Isaac-Renton has an MD and a Diploma in Public Health from the University of Toronto. After developing an interest in communicable diseases, she obtained her Fellowship in the Royal College of Physicians and Surgeons of Canada in Medical Microbiology at the University of British Columbia. She has worked as a Medical Microbiologist at the Children’s and Women’s Hospital, Vancouver Hospital and Health Sciences Centre (VHHSC) and the BC Centre for Disease Control (BCCDC).
After being Head of Division of Medical Microbiology and Infection Control, she also took on Acting Medical Director position for the Department of Pathology and Laboratory Medicine at VHHSC. Most recently, she became Director, Laboratory Services, BCCDC, where she is also the Microbiologist in charge of Environmental Services. In May, 2005, Dr. Isaac-Renton also took on responsibilities of Program Director, Microbiology and Public Health, PHSA Laboratories.
She is a Professor, Medical Microbiology, in the Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia. Some of her current other activities are Vice Chair of the Canadian Public Health Laboratory Network, Co-Chair Provincial Infection Control Network, Co-Chair PHSA Laboratories, Member UBC Department Executive, PLCO Microbiology Clinical Advisory Group and PLCO Quality Advisory Group, Board member for the Premier’s Leading Edge Endowment Fund, and a member of the Canadian Water Network (CWN). She holds external grant funding from both CWN and CIHR.
Power point presentation, part I
Power point presentation, part II
March 20: Osteoporosis Prevention and Treatment - A Physiology Based Practical Approach
Dr. Jerilynn Prior
This TeleHealth Video Broadcast, looked at how bone renews itself, the roles of diet and lifestyle in
bone balance, and the changes in normal bone remodeling across the life cycles of women and men. You
gained information to ensure your own bone health, and to assist others to understand and prevent bone loss.
She also discussed osteoporosis, the importance of fractures, and the kinds of therapies available and helpful
for fracture prevention.
No presentation is available
February 28: Blood Tissues and SNOT
- Building Better Living Through Plastics
Dr. Mark Scott discussed the "immunocamouflage" of tissues, cells, and viruses, and present the pioneering work of his laboratory in using immunocamouflage to prevent allorecognition of foreign cells and tissues for use in transfusion and transplantation medicine, and in the prevention of viral infection. This research has focused on transfusion medicine (Red Blood Cells, Platelets, and White Blood Cells), and on the prevention of viral infections in both the blood banking environment (e.g., CMV) and as a prophylactic approach to the prevention of respiratory viral infections (e.g., common cold). Dr. Scott holds a Ph.D. in Pathobiology from the University of Minnesota, and is currently Associate Director of Intellectual Property and Business Development and Senior Scientist for Canadian Blood Services, and Clinical Professor in the Dept. of Pathology and Laboratory Medicine and the Centre for Blood Research at UBC.
Presentation in PDF format
January 17: Hemolytic Transfusion Reactions
Acute hemolytic transfusion reaction is a rare but serious complication of blood transfusion. It is a well known fact that most hemolytic transfusion accidents are due to clerical errors.
This presentation reviewed the pathophysiology of both acute and delayed hemolytic transfusion reactions, followed by routine and special transfusion service laboratory investigation.
Finally, the prevention of acute hemolytic transfusion reaction and reducing the risk of delayed hemolytic transfusion reaction
was discussed.
The presenter, Eric Ching ART; MT(ASCP)SBB, was born and raised in Hong Kong and completed his MT training
at the University of Hawaii. The following year, he finished his
internship at St. Francis Hospital in Honolulu and immigrated to Kamsack, Saskatchewan. He began his blood banking career at the Calgary Red Cross, becoming acharge technologist in component production and
quality control. For the next 18 years, working at the Foothills Medical Centre in Calgary, Eric taught and learned from many students, technologists, ART candidates, pathology residents, and hematology fellows. He also helped establish the bone marrow and stem cell transplant cryopreservation and purification program in Calgary.
Eric has been involved in continuing education activities with SAIT since 1986, and with CSMLS since 1994. Eric now works as the Western Canada Blood Bank System Specialist and education specialist for Dominion Biologicals Ltd and
ImmucorGamma. Through sponsorships from DBL and ImmucorGamma, Eric conducts workshops in blood group serology and presents seminars regularly in provincial and national meetings. He is also a chartered member of the MODE
Group, which promotes continuing education to medical laboratory technologists and other health care professionals in conjunction with CSMLS. In May, 2007, at the Canadian
Society for Transfusion Medicine, Eric won the Dr. Donald
Buchanon Memorial Lecture Award for his contribution to transfusion medicine in Canada.
|
| TeleHealth Seminars 2007 |
May 10: Making the Most of Your Hepatitis Testing
This TeleHealth seminar focused on the fascinating issue of the clinical relevance of viral hepatitis testing in the laboratory, since the causative agent in viral hepatitis cannot be diagnosed on clinical grounds alone. An update and review, the seminar included the biology, epidemiology, and serology of hepatitis A, B, and C; examination of acute and chronic serological profiles; and an explanation of both antigen and antibody involved in the humoral response.
The seminar's objectives included interpretation of the Acute Hepatitis Panel; identification of the serological tests for hepatitis A, B, and C; and recognition of the clinical utility of molecular assays in chronic viral hepatitis. The seminar enabled participants to identify the current serological and molecular tests available for the clinical assessment of viral hepatitis.
The presenter, Dr. Luis Lasalvia, MD, MBA, has clinical experience as an MD as well as a three-year post-doctoral position in hospital Endocrinology. With a BA in Marketing and an MBA, he has worked for over ten years as a medical and marketing manager in the pharmaceutical and diagnostic industry. Currently working in Scientific Affairs at Bayer Diagnostics, he conducts scientific forums and grand rounds in his areas of specialty. He has extensive experience as a guest speaker, and presents at over 100 events each year in Canada, the US, and overseas.
Presentation in PDF format
March 15: Working Together: Molecular Diagnostics in the Clinical Laboratory by Alana Bergstrome, MSc
Molecular technologies are powerful tools when used together with traditional laboratory methods to provide optimal patient care. This presentation examined molecular technologies and their applications in the clinical environment. Basic molecular theory, specific examples of testing methodologies and case studies were included.
The presenter is Supervisor of Molecular Diagnostics, Operations and Marketing with MDS Metro Labs. She holds a Masters degree in Medical Genetics from UBC and is certified as a Clinical Specialist in Molecular Biology by the National Credentialing Agency in the US. She has 15 years' experience in laboratory research and development and applied diagnostics in both the public and private sectors, and has 17 abstract and peer-reviewed publications at conferences and in scientific and medical journals.
February 15: Alternatives to Blood Transfusion by Eric Ching ART, MT(ASCP)SBB. Despite great improvements in transfusion safety in recent years, transfusions of blood components and products are still far from risk-free. Ching, an established expert in transfusion medicine, looked at the appropriateness of transfusion of blood components from the perspective of technologists, enabling them to become better “gate-keepers” in reducing the incidence of unnecessary transfusion. Pharmacological agents, artificial hemoglobin, intraoperative hemodilution, and autologous pre-deposit of blood were also discussed. Born in Hong Kong, Ching trained and practiced in Hawai'i before spending several years with the Calgary Red Cross. He has taught transfusion medicine to student technologists, ART candidates, pathology residents, and hematology fellows at Foothills Medical Centre in Calgary, and later at SAIT. Ching is currently western Canada Territory Manager and Product and Education Specialist for Dominion Biologicals Ltd. and ImmucorGamma.
Presentation in PDF format
|
| TeleHealth Seminars 2006 |
November 30: Osteoporosis by Dr. Jerilynn C. Prior, UBC Professor of Endocrinology and Metabolism. Dr. Prior spoke about the latest research and practical resources available to aid women with their bone health. Osteoporosis can affect women throughout the stages of their lives - teenage, premenopausal, midlife, and menopausal years. Dr. Prior also discussed prevention and treatment of osteoporosis. Dr. Prior is also Research Director of the Centre of Menstrual Cycle and Ovulation Research (CeMCOR) at UBC.
slides and an outline from Dr. Prior's TeleHealth will be available soon
October 19: Iron Hemochromatosis by Dr. Gillian Lockitch, Director of the Department of Pathology & Lab Medicine, UBC/Children's & Women's Health Centre of BC. Dr. Lockitch offered an update on the recognized genetic variants of hemochromatosis, presented typical case studies, examined genotype/biochemical and clinical phenotype relationships, and suggested an approach to diagnosing and confirming haemochromatosis in children and young adults.
Power point Presentation
May 25: Biochemical Cardiac Tests, Before, During and After the Infarct by Dr. J Heathcote, Director of Chemistry at BC Biomedical Laboratories, Medical Director of the Riverview Provincial Toxicology Centre, and Regional Biochemist for the Fraser Health Authority presents some commonly used cardiac markers that are used to evaluate the future risk of myocardial infarct, the diagnosis of an infarct, and the risk of future adverse events (eg. re-infarct, congestive heart failure) after the event. Power point Presentation and Slide Handouts
April 27: The ABCs of AROs - Antibiotic Resistant Organisms by Dr. Diane Roscoe, MD, Clinical Professor, Division Head Medical Microbiology and Infection Control in the Dept of Pathology & Lab Medicine, UBC/VHHSC. Do you know the ABCs of Antibiotic Resistant Organisms (AROs) - MRSA, VRSA, VRE, ESBL, MDRTB? This seminar explains what these organisms are, how we find them in the laboratory, what we do about them, and why we care.
Power point Slides and Slide Handouts
March 23: Use of Chemistry Tests in Kidney Disease by Dr. J. Heathcote (BC Biomedical). Dr. Heathcote offers an overview of the functions of the kidney as they relate to filtration, fluid and electrolyte balance, acid-base homeostasis, and secretion of waste products, as well as a discussion of laboratory tests and their interpretation.
Power point Slides and Slide Handouts
Back to Top
|
MLA Education Day 2010 - North and South |
MLA Education Day South
"2010 Striving for Excellence"
click for printable poster
Saturday May 1st, 2010
Douglas College
“INR's - Heart Attach and Stroke ” Speaker: Dr. David Ferguson, Medical Director, BC Biomedical
“The World of Travel Medicine” Speaker: Marlene Burrows, Langara College School of Nursing, Primed Educaiton Associates
“Pre-Analytical Errors Expanded” Speaker: Dr. Richard Cleve, Medical Biochemist, Fraser Health
“Acquired Cardiac Diseases in Childhood, Teenage and Adult” Speaker: Ramon Estrella, Instructor in the Cardiology Program at Stenberg College.
_____________________
MLA Education Day North
click for printable poster
Saturday April 17th, 2010
Prince George, BC at PGRH
“Pre-Analytical Errors” Speaker: Yvonne Yaschuk, ART.
MLT Instructor at CNC
“ECGs for MLAs” Speaker: Janis Ross, Cardiology Technologist, Prince George Regional Hospital
“ABO and Rh” Speaker: Pam Danesin, Charge Technologist, Transfusion Medicine, Prince George Regional Hospital.
“BNP and Cardiac Markers” Speaker: Dr Grant Roden, Laboratory Director, Prince George Regional Hospital
Back to Top |
| MLA Education Day 2009 |
"An Internal Experience"
Saturday April 25, 2009
We are confident you will enjoy this special professional development day for medlab assistants and leave with a new understanding of the importance of your role in quality patient care. Learn from our speakers, learn from your peers.
TOPICS...
“The ABO’s of Rh” - Eleanor Hooley
Presentation Handouts-full presenation not available
“Helping You Help Kids Cope” - Bindy Sweett
No handouts available - presentation was more interactive
“Life Threatening Arrhythmias.” - Ramon Estrella
Presentation , PDF format
“Today’s Medical Technology Student – Why Aren’t
They Like Us When We Trained?” - Anne Murray
No presentation available due to copyrighted material
For more information click here
Back to Top |
| MLA Education Day 2008 |
April 12 , 2008
Douglas College, New Westminster
Topics:
Cholesterol by Dr. Richard Cleve, A Biochemistry Pathologist.
Presentation Handout
DNA Genetic Testing by Dr. Richard Yu, Pathologist, Fraser Health.
Presentation Handout
ECGs for MLAs by Cathie Cousins, RN BsN Certified Cardiovascular Nurse in Canada - CCN(C) and Critical Care Consultant.
Presentation not available
Workplace Issues for MLA's by Kim Connolly, Head Instructor, West Coast College, MLA program.
Presentation Handout
Organized by the BCSLS MLA Education Committee.
Back to Top |
| MLA Education Day 2006 |
May 13, 2006
Douglas College, New Westminster
Topics:
The Future for MLAs by Rene Maier, MLA at MDS Metro, Camoson College and BCSLS Prof. Dev. Director.
Pediatric Blood Collection by Brett Maletic, MLA Children & Women's Heath Centre.
Power Point Slides Slide Handouts
Advanced ECGs for MLAs by Cathie Cousins, RN BsN Certified Cardiovascular Nurse in Canada - CCN(C) and educator.
Power point Slides Slide Handouts
Legal and Ethical Issues by Joan Mitchell, Ed.D. MLT and Adjunct Associate Professor, University of Victoria.
Power point Slides Slide Handouts
Organized by the BCSLS MLA Education Committee.
Back to Top
March 6 , 2010 9:00 - 4:30
Justice Institute - New Westminster-map
"the Real CSI"
CSI: Crime Scene Investigation is an American crime / drama television series that trails the investigations of a team of Las Vegas forensic scientists as they unveil the circumstances behind mysterious and unusual deaths and other crimes. So popular is this made for TV series that its impact has morphed from purely fictional entertainment to real life crime and punishment.
Now you have an opportunity to learn about and witness “the Real CSI” – a one-day conference sponsored by the BC Society of Laboratory Science [BCSLS] in partnership with the new Centre for Forensic Research at Simon Fraser University and the BCIT Centre for Forensics and Security Technology Studies.
This one-day conference will feature several of the most renowned forensic experts who now make up the scientific staff of both Centres.
more information...click here
Speakers Bios - click here
9:00 am:
Dr. Dean Hildebrand, Ph.D., Forensic Biologist
"Behind the Lab Door - Technological Advances in Forensic DNA Analysis and Their Impacts on Human Identification"
10:30 am:
Dr. Gail S. Anderson, Ph.D., Forensic Entomologist
"Effects of Body Disposal Techniques on Forensic Entomology "
1:00 pm:
Dr. Lynne Bell,Ph.D., Forensic Anthrolpologist
"Micro-taphonomy: decoding the post-mortem environment"
2:30 pm:
Dr. Rolf Mathewes,Ph.D., Forensic Botanist
" Pollen and Spores: Microscopic Aides in Criminal Investigation"
|
| National Medical Lab Week |
Click to View Our Video for National Medical Lab Week 2007
Click to Hear Our Radio Spot for National Medical Lab Week 2009
Click to View Our Video for National Medical Lab Week 2009
Letter from the Minister
Back to Top
|
| Toxicology and the Natural World |
Saturday, November 19, 2005
Taylor Fidler Lecture Theatre
Jim Pattison Pavilion, Vancouver General Hospital
Role of Ginkgo Biloba in Drug and Chemical Toxicity Dr. Thomas K. H. Chang. Dr. Chang is Associate Professor, Faculty of Pharmaceutical Sciences, UBC.
Will That Be Kava-Kava or Khat? Mr. Rick Ulrich. Mr. Ulrich is Program Coordinator, Instructor and Toxicologist with the Forensic Science Technology Program in the School of Computing and Academic Studies at BCIT.
High Mercury Exposure Through Excessive Seafood Consumption:A Concern for our Asian Community? Dr. Andre Mattmam. Dr. Mattman is Laboratory Physician at Children and Women’s Health Centre. He oversees trace element and heavy metal testing, prenatal screening and other areas of the chemistry laboratory.
Forensic Botany: Past, Present and Future Dr. Rolf Matthewes. Dr. Mattewes, Professor of Biological Sciences at SFU will outline the basic principals of forensic botany, review its history and talk specifically about several BC cases where it has been used.
Back to Top
|
Paradoxes of Perimenopause: Surviving and Thriving |
|
Thursday, October 27th, 2005
Telehealth Video Broadcast
Dr. Jerilynn C. Prior, UBC Professor of Endocrinology and Metabolism
Dr. Prior speaks about the latest and most practical resources available to aid women with their Perimenopause to menopause transition. She draws upon research conducted for her recent book Estrogen's Storm Season
Stories of Perimenopause. Dr. Prior has studied women's menstrual cycles, perimenopause, and the causes for and treatment of osteoporosis. She is also Research Director of the Centre of Menstrual Cycle and Ovulation Research (CeMCOR) at UBC.
Resources:
Website: CeMCOR
Slide Presentation: [not yet available]
Handouts: [PDF doc not yet available]
Reading Materials: Estrogen's Storm Season
|
| |
|
OBJECTIVE
BCSLS Newsletter Archives
Issues No. 1-19 (2005-2008)
Issue No. 20 (Summer 2009)
Issue No. 21 (Winter 2010)
|